Psoriasis Treatment Market Analysis

  • Report ID: 4625
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Psoriasis Treatment Market Analysis

Type (Plaque Psoriasis, Psoriatic Arthritis)

The global psoriasis treatment market is segmented and analyzed for demand and supply by type into plaque psoriasis, psoriatic arthritis and others. Out of which the plaque segment is anticipated garner the largest revenue by the end of 2037. The growth of this segment can be attributed to growing prevalence of plaque psoriasis among population. For instance, the most typical form of psoriasis is plaque. Approximately 5 million adults are impacted. Plaque psoriasis affects between 70% and about 80% of psoriasis sufferers. Hence the demand for psoriasis treatment is estimated to increase. Psoriasis vulgaris, also known as plaque psoriasis, is a persistent (chronic) autoimmune condition that accelerates cell division. Further, plaque psoriasis could cause itchiness and large amount of pain, which may give burning or sting sensation. Hence, treating plaque psoriasis is necessary. Therefore, systematic drugs are usually employed to the patient suffering with the same. These systematic drugs are known for regulating immune system and is also estimated to reduce the prevalence of cell growth.

Route of Administration (Oral, Parenteral/systematic, Topical)

The global psoriasis treatment market is also segmented and analyzed for demand and supply by route of administration into oral, parenteral/systematic and topical segment. Amongst these segments, the parenteral/systematic segment is anticipated to hold the largest market share by the end of 2037, owing to its high convenience. Large number of people estimated it to be one of the easiest application method as compared to other methods. Usually parenteral/systematic treatment is recommended only if the patients has moderate or severe psoriasis. Less than 4% of the body is affected by mild psoriasis; about 4% to 10% is termed moderate; and more than 9% is considered severe. Hence, as it affects huge part of body the importance of treatment has grown over the years.

Our in-depth analysis of the global market includes the following segments:

      By Drug Class

  • TNF Inhibitors
  • Interleukins Inhibitors
  • Others

      By Type

  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others

      By Route of Administration

  • Oral
  • Parenteral/Systemic
  • Topical

      By Distribution Channel

  • Hospital
  • Retail Pharmacies
  • Online Pharmacies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4625
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of psoriasis treatment is evaluated at USD 32.76 million.

The psoriasis treatment market size was over USD 30.67 million in 2024 and is anticipated to exceed USD 88.31 million by the end of 2037, witnessing over 8.4% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of psoriasis and high demand for the treatment amid pandemic will boost the market growth.

North America industry is set to account for largest revenue share by 2037, impelled by strong presence of well- equipped infrastructure and rising long-term investment and advanced healthcare facilities in the region.

The major players in the market include LEO Pharma A/S, Amgen Inc., UCB S.A., Merck & co. Inc., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd., Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample